Using human stem cells to study communication between nerves and muscles in neuromuscular diseases.

Human-iPSC derived neuromuscular junctions as a model for neuromuscular diseases.

NIH-funded research Case Western Reserve University · NIH-10727888

This study is exploring how special stem cells can help us create models of the connections between nerves and muscles, which are important for movement, to better understand diseases like ALS and find new ways to treat them.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCase Western Reserve University NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-10727888 on NIH RePORTER

What this research studies

This research investigates how human-induced pluripotent stem cells (iPSCs) can be used to create models of neuromuscular junctions, which are critical for muscle contraction. By focusing on the complex interactions between motor neurons and muscles, the research aims to better understand the mechanisms behind neuromuscular diseases like Amyotrophic Lateral Sclerosis (ALS). The approach involves developing functional models that replicate the communication pathways affected in these diseases, which could lead to more effective treatments. Patients may benefit from insights gained through these models that could inform future therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults diagnosed with neuromuscular diseases, particularly those with Amyotrophic Lateral Sclerosis.

Not a fit: Patients with neuromuscular diseases that are not related to motor neuron degeneration may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential treatments for neuromuscular diseases, offering hope to patients suffering from conditions like ALS.

How similar studies have performed: While there have been successful studies using iPSC models in other areas, this specific approach to studying neuromuscular junctions in the context of ALS is relatively novel.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Amyotrophic Lateral Sclerosis Motor Neuron DiseaseGehrig's DiseaseLou Gehrig Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.